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Introduction: The objective of this retrospective study was to investigate clinical and pathologic char-
acteristics of differentiated thyroid cancer in elderly patients and to evaluate the results of surgical
treatment in this age group. Methods: The clinical records of patients who underwent total thyroidec-
tomy between 2002 and 2012 with histopathological diagnosis of differentiated thyroid cancer were
analyzed. Patients were divided into two groups: those 65 years old or older were included in group A
(101), those younger in group B (354). Results: The mean surgical time was 100.9 ± 30.5 min in group A
and 100.7 ± 27.6 in B. Postoperative stay was signiﬁcantly longer in group A (2.8 ± 1.5 days vs 2.4 ± 0.7;
p < 0.01). Classic papillary carcinoma was more frequent in group B, whereas follicular variant of
papillary carcinoma and tall cell carcinoma in A. In group B node metastases were nearly twice. In Group
A transient hypoparathyroidism occurred in 25 patients (24.8%), permanent hypoparathyroidism in 4
(4%), hematoma in 6 (5.9%), recurrent nerve palsy in 2 (2%), and wound infection in 2 (2%). In group B
transient and permanent hypoparathyroidism occurred in 48 and 7 patients respectively (13.6% and 2%),
hematoma in 4 (1.1%), recurrent nerve palsy in 5 (1.4%), and wound infection in 1 (0.3%). Conclusions:
Differentiated thyroid carcinoma is more aggressive in elderly patients for biological causes connected to
age and to histotype but also for the diagnostic delay. Thyroid surgery in elderly patients is safe when the
procedure is carried out by experienced staff. Total thyroidectomy is the surgical operation of choice.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The incidence of differentiated thyroid cancer (DTC) increases
with age [1e6]; between 2.5% and 12% of DTC occur in individuals
older than 65 years [7].
Thyroid cancer is the only malignancy with age as a prognostic
indicator in the majority of staging systems [4,6,8]; the mortality
climbs gradually starting at age 40e45 [4,8]. Elderly patients often
present with more aggressive forms of DTC, larger tumors, more
extensive local growth, or distant metastases [1,9,10]. A steady
decline in survival rates has been reported with increasing age,T3, free T3; FT4, free T4; TSH,
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Different histopathological patterns, a poorer general physical
condition, and delayed diagnosis are the major reasons for the poor
prognosis of these patients [11]. Thyroid cancer recurrence rates
have also been shown to be inﬂuenced by age [2,4].
The management of DTC in older patients remains controversial
[4]. The literature regarding outcomes in this age group remains
scarce and analyses of incidence, characteristics, and prognosis in
elderly patients are rarely reported [1,7,12e15].
The objective of this retrospective study was to investigate the
clinical and pathologic characteristics of DTC in elderly patients and
to evaluate the results of surgical treatment in this age group.2. Methods
The clinical records of patients who underwent total thyroid-
ectomy between 2002 and 2012 in our Department of Surgical
Sciences at the University of Cagliari with histopathological diag-
nosis of DTC were analyzed. Patients with incomplete data and
those lost at follow up were excluded. 455 patients were included
in this retrospective study. For each patient preoperative work-up.
Table 1






y.o.) (n ¼ 354)
p value
Sex
 Male 21 (20.8%) 76 (21.5%) 0.9929 ns
 Female 80 (79.2%) 278 (78.5%)
Age (years) 71.3 ± 5.3 45.6 ± 11.6 0.000001 P < 0.01
Indications to surgery
 Indeterminate or sus-
picious nodule on
cytology
33 (32.7%) 112 (31.6%) 0.5128 ns
 Diagnosis of carcinoma
on cytology
6 (5.9%) 38 (10.7%)
 Suspicious nodule on
US
32 (31.7%) 112 (31.6%)
 Benign disease (multi-
nodular goitre and
hyperthyroidism)
30 (29.7%) 92 (26%)
US: Ultrasound.
Table 2
Surgical procedure and postoperative stay.

















5 (5%) 10 (2.8%)
Surgical time (min) 100.9 ± 30.5 100.7 ± 27.6 0.4956 ns
Postoperative stay (days) 2.8 ± 1.5 2.4 ± 0.7 0.0009 P < 0.01
Table 3
Histopathological diagnosis.















37 (36.6%) 86 (24.3%)
 Tall cell carcinoma 9 (8.9%) 26 (7.3%)
 Follicular
carcinoma
10 (9.9%) 35 (9.9%)
 Hurtle cell
carcinoma




1 (1%) 2 (0.6%)
Multicentric
carcinoma
36 (35.6%) 109 (30.8%) 0.422 ns
Locally invasive
carcinoma
36 (35.6%) 110 (31.1%) 0.455 ns
Node metastases 7 (6.9%) 43 (12.1%) 0.1942 ns
P.G. Calo et al. / International Journal of Surgery 12 (2014) S140eS143 S141consisted of free thyroid hormone (FT3, FT4) and thyrotropin (TSH)
blood measurements, high resolution ultrasound (US) of the neck
and ﬁbrolaryngoscopy for evaluation of vocal fold motility. For
patients with suspicious nodules, US-guided ﬁne-needle aspiration
cytology (FNAC) was performed. All operations were performed by
the same three experienced endocrine surgeons. Serum calcium
and intact parathyroid hormone (PTH) were assayed on ﬁrst post-
operative day, and then on the basis of clinical evaluation. Patient
demographics and postoperative complications were recorded,
including postoperative hematoma, recurrent laryngeal nerve
injury, hypoparathyroidism and wound infection. Hypoparathy-
roidism (deﬁned as a PTH level <10 pg/ml) was considered per-
manent if it lasted more than 6 months. Recurrent laryngeal nerve
palsy was deﬁned as vocal fold paralysis assessed by postoperative
ﬁbrolaryngoscopy and was considered permanent if persisting for
more than 6 months after surgery.
Postoperative radioablation iodine therapy was administered
according to guidelines (gross extrathyroidal extension, primary
tumor size greater than 4 cm, distant metastases, and selected
patients with signiﬁcant risk of recurrence with primary tumors
ranging from 1 to 4 cm conﬁned to the thyroid).
Follow-up consisted of neck US examination and monitoring of
Tg and TgAb levels every six months during suppressive L-thyroxine
treatment; a serum Tg level of 0.2 ng/ml was taken as undetectable.
In those with suspicious recurrence a whole-body 131I scanning
after recombinant human thyrotropin (rhTSH) stimulation was
performed. Diagnosis of disease recurrence in the cervical lymph
nodes was based on US-guided FNAC, Tg washing of FNAC aspirates,
and serum Tg level monitoring.
Patients were divided into two groups: those 65 years old or
older were included in group A, those younger in group B.
Data were analyzed with descriptive statistics. For categorical
variables, the Pearson's chi-squared (exact) test was used; for
qualitative variables Student's t-test was used. Differences between
the two groups were considered statistically signiﬁcant for P value
<0.05.
The study was approved by the Institutional Ethical committee
of the University of Cagliari.
3. Results
A total of 455 patients were included in the study; 101 were 65
years old or older and were included in group A, whereas the other
354 were younger and were included in group B. Preoperative
diagnosis with ﬁne-needle aspiration biopsy was available from
189 patients: an indeterminate or suspicious nodule was found in
145 patients and a carcinoma in 44 patients. In 144 patients a
thyroid malignancy was suspected on physical examination and
ultrasound features of the nodule. In 102 patients indication to
surgery was for benign disease and DTC was an occasional ﬁnding
after thyroidectomy. Demographic data and indications to thy-
roidectomy are reported in Table 1. All the patients underwent total
thyroidectomy, in 89 cases (13 cases in group A and 76 in group B)
associated with central neck compartment lymphadenectomy;
concomitant modiﬁed lateral neck dissection was performed in 15
cases (5 in group A and 10 in group B). The mean surgical time was
100.9 ± 30.5 min in group A and 100.7 ± 27.6 min in group B (see
Table 2). Postoperative stay was signiﬁcantly longer in group A
(2.8 ± 1.5 days vs 2.4 ± 0.7; p < 0.01). Histopathological data are
reported in Table 3. Classic papillary carcinoma was more frequent
in group B, whereas follicular variant of papillary carcinoma and tall
cell carcinoma in group A (p < 0.01). In group B node metastases
were nearly twice as many as in the other group (7 patients, 6.93%
in group A; 43 patients, 12.15%, in group B). We had no mortality in
both groups. In Group A transient hypoparathyroidism occurred in25 patients (24.8%), permanent hypoparathyroidism in 4 (4%),
postoperative hematoma in 6 (5.9%), recurrent laryngeal nerve
palsy in 2 (2%), and wound infection in 2 (2%). In group B transient
and permanent hypoparathyroidism occurred in 48 and 7 patients
respectively (13.6% and 2%), postoperative hematoma in 4 (1.1%),
P.G. Calo et al. / International Journal of Surgery 12 (2014) S140eS143S142recurrent laryngeal nerve palsy in 5 (1.4%), and wound infection in
1 (0.3%). Postoperative complications are summarized in Table 4.
There were no statistically signiﬁcant differences in local re-
currences (7 cases, 6.9%, in group A and 19 patients, 5.4%, in group
B).
4. Discussion
An exact deﬁnition of the geriatric patient is not available in the
medical literature. Various publications use different age deﬁni-
tions, eg. 60, 65, 70, 75, and 80 years [16,17]. As other authors
[1,2,15], we have chosen to use as a limit the age of 65 years with
the aim of obtaining a larger series.
The prevalence of DTC increases signiﬁcantly with age [13,16,17]
and age at diagnosis was identiﬁed as a major independent prog-
nostic factor in several large retrospective series [2,6,7,11,13,16]. In
the report of Vini [7], for any 10-year difference in age, there was a
near doubling of risk. The risk of recurrence and death increased
linearly with age [7].
DTC in the elderly can have a more aggressive biologic behavior
and a worse prognosis [5e7,12e14,16e19]. This might be due to the
higher prevalence of pathologic risk factors like vascular invasion,
extracapsular extension, and follicular type in older patients
[5,9,13,16e19]. Park et al. [5] showed that patients  65 years
demonstrated more aggressive disease with multiple, larger tu-
mors and more advanced-stage disease, non papillary histology,
and extra-thyroidal extension. Biliotti et al. [18] report a higher rate
of larger tumors, a more elevated incidence of extraglandular
spread and a higher rate of distant metastases at the time of sur-
gery. In addition, the effectiveness of radioiodine therapy decreases
in the elderly due to the fact that the uptake of 131I is age-
dependent [7,9,18]. The reduced response is probably to be attrib-
uted to the diminished differentiation of follicular and papillary
carcinoma in geriatric patients [18]. Well-differentiated carcinomas
that display a more aggressive histotype, such as sclerosing and
tall-cell papillary variants, have a higher incidence and an unfa-
vorable evolution in patients aged over 50 years of age [13,20].
In the experience of Vini [7], at presentation 70% of patients had
locally advanced disease, 44% of patients had associated lymph
node disease, and 23% of patients had an evidence of distant me-
tastases; 21% developed locoregional recurrent disease, and 15% of
patients developed distant metastases.
In our experience there was a higher incidence of follicular
(36.6% vs 24.3%) and particularly tall cell papillary variants (8.9% vs
7.3%) and a lower incidence of typical papillary carcinoma, con-
ﬁrming the data reported in the literature. We also observed larger
tumors in the elderly patients (20.8 ± 15.9 vs 16.3 ± 10.6) while
thyroid weight was 37.4 ± 34.3 vs 28.1 ± 22.6. These data can be
attributed to the frequent association of large untreated goiters and
to a delayed diagnosis of DTC in the elderly as reported by otherTable 4
Postoperative complications and local recurrence.
Group A (65 y.o. and
older) (n ¼ 101)
Group B (younger




 Transient 25 (24.8%) 48 (13.6%) 0.0107 p < 0.01




2 (2%) 5 (1.4%) 0.9603 ns
Postoperative
haemorrhage
6 (5.9%) 4 (1.1%) 0.011 p < 0.01
Wound infection 2 (2%) 1 (0.3%) 0.9603 ns
Local recurrence 7 (6.9%) 19 (5.4%) 0.7232 nsauthors [11,18]. The incidence of lymph node metastasis was lower
(6.93% vs 12.15%) as reported by others [10].
The recurrence rate, like the rate of mortality, for DTC is highest
among elderly patients [2,8,18]. Lymph node relapses increase in
the elderly patients group [13,21]. In the report of Vini [7], the
median time from the end of therapy to clinical recurrence was
only 9 months, compared with 34 months in the whole series of
1390 adults with DTC. Age inﬂuences the probability of developing
recurrent disease, the interval from initial treatment to recurrence,
and the duration of survival after recurrence [7]. In the report of
Toniato [10], the incidence of recurrence was earlier and more
frequent in elderly patients, and the outcome of papillary cancer
was signiﬁcantly worse in older than in younger patients. The
worse prognosis can have two reasons: the ﬁrst could be a more
advanced stage, particularly IV stage; the second, could be a
reduced radioiodine uptake [10].
We found no statistically signiﬁcant difference in the incidence
of recurrence. This is probably related to the fact that the surgical
treatment was not different in the different age groups in our
experience: we performed in all patients a total thyroidectomy
associated to a central neck dissection in high risk patients and in
presence of suspicious nodes as previously reported [21e23].
Few reports exist concerning thyroid surgery and survival of
thyroid cancer in the elderly patient [10,17]. Surgery in elderly
patients has been considered to be more hazardous than in a
youthful population; this increased risk appears to be related to the
presence of comorbidities rather than to age alone [15]. In the
experience of Passler [17] the most common comorbidity was hy-
pertension followed by cardiac disease and arrhythmia, with most
patients having one or two comorbidities; eighteen percent of their
elderly patients had 3 or more comorbidities [14]. For these rea-
sons, patients 80 years of age can undergo thyroid surgery with
signiﬁcantly higher morbidity [14]; efforts should be made to
identify surgical patients earlier than the 8th decade of life and
surgery should not be delayed, since delay may lead to the risk of
added comorbidities at a more advanced age [14].
Elderly Americans aged 65 years with DTC 1 cm receive less
aggressive treatment with near-total or total thyroidectomy and
radioactive iodine therapy than their younger counterparts [5]; no
surgery and no radioactive iodine therapy were predictors of worse
survival in the report of Park [5]. In the report of Vini [7], only 41% of
patients underwent total thyroidectomy due mainly to the poor
condition of the patient or to the advanced tumor stage, precluding
deﬁnitive surgery.
We always performed total thyroidectomy and we found no
statistically signiﬁcant difference in central or lateral neck dissec-
tion, having always treated the elderly patients in the same way as
younger patients.
Morbidity associated with thyroidectomy in elderly patients
may be higher than in youthful patients [15]. Some studies reported
a higher incidence of postoperative hematoma in their elderly
population [15,17]. Seybt [15] reported that older patients were
more likely to be readmitted than their younger counterparts and
readmission was usually related to transient hypocalcemia.
In our experience the post-operative hospital stay was 2.8 ± 1.5
days vs 2.4 ± 0.7 and we had no mortality. The longest hospital stay
was related both to comorbidities and postoperative complications.
Incidence of transient hypoparathyroidism was 24.75% vs 13.56%
and of postoperative hematoma 5.94% vs 1.13%. The incidence of
postoperative bleeding may be related to a higher frequency of use
of anticoagulants or antiplatelet drugs in the elderly population
[24,25], while the higher incidence of transient hypoparathyroid-
ism may be attributed to the presence of larger tumors and
advanced cancer in this age group [26,27].
P.G. Calo et al. / International Journal of Surgery 12 (2014) S140eS143 S143In conclusion, DTC generally is more aggressive in elderly pa-
tients for biological causes connected to the age and to the histo-
type but also for the considerable diagnostic delay. Thyroid surgery
in elderly patients is safe and no more dangerous than surgery in
younger patients when the procedure is carried out by experienced
staff. Age alone should not be a consideration when deciding
whether or not to operate. Total thyroidectomy is the surgical
operation of choice, because age alone does not represent an
important factor of perioperative mortality and morbidity.
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